DANIEL B SOLAND Insider Trading $KALV KalVista Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL B SOLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL B SOLAND. DANIEL B SOLAND is VP; President, Chiron Vaccines in CHIRON CORP ($CHIR) and Chief Operating Officer in IDERA PHARMACEUTICALS, INC. ($IDRA) and in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in KalVista Pharmaceuticals, Inc. ($KALV).
DANIEL B SOLAND in KalVista Pharmaceuticals, Inc.
Trading Symbol: KALVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL B SOLAND: Director
Holdings: 2,038 shares
Latest Transaction: Oct 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL B SOLAND in KalVista Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, CHIR, IDRA, KALV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 02 2020 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Option Exercise | A | 12.88 | 7,000 | 90,160 | 7,000 | |
Oct 02 2020 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Option Exercise | A | 12.88 | 7,000 | 90,160 | 7,000 | |
Sep 30 2019 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Buy | P | 11.87 | 7,962 | 94,498 | 10,000 | 2 K to 10 K (+390.68 %) |
Sep 30 2019 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Buy | P | 11.90 | 2,038 | 24,252 | 2,038 | 0 to 2 K |
Apr 23 2019 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Option Exercise | A | 26.40 | 14,000 | 369,600 | 14,000 |
Page: 1